Susquehanna International Group, LLP Neogenomics Inc Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Neogenomics Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 69,569 shares of NEO stock, worth $692,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,569

Previous 28,747 142.0%

Holding current value

$692,211

Previous $424,000 170.28%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.0 - $18.43 $530,686 - $752,349	40,822 Added 142.0%	69,569 $1.15 Million
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $118,188 - $156,378	-8,820 Reduced 23.48%	28,747 $424,000
Q2 2024 Aug 15, 2024	BUY	$13.01 - $15.77 $488,746 - $592,431	37,567 New	37,567 $521,000
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $294,737 - $523,556	25,256 Added 51.46%	74,339 $1.2 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $419,952 - $616,967	-34,564 Reduced 41.32%	49,083 $603,000
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $1.7 Million - $2.39 Million	-120,701 Reduced 59.07%	83,647 $1.34 Million
Q1 2023 May 16, 2023	BUY	$9.09 - $19.45 $1.41 Million - $3.02 Million	155,123 Added 315.13%	204,348 $3.56 Million
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $674,192 - $1.26 Million	-104,526 Reduced 67.98%	49,225 $454,000
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $483,319 - $793,848	-61,491 Reduced 28.57%	153,751 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $1.02 Million - $2.02 Million	144,302 Added 203.41%	215,242 $1.75 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $117,081 - $186,201	-3,840 Reduced 5.14%	70,940 $2.42 Million
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $2.27 Million - $2.86 Million	54,484 Added 268.45%	74,780 $3.61 Million
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $2.07 Million - $2.93 Million	-56,630 Reduced 73.62%	20,296 $917,000
Q1 2021 May 17, 2021	SELL	$41.56 - $59.88 $840,301 - $1.21 Million	-20,219 Reduced 20.81%	76,926 $3.71 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $2.8 Million - $4.38 Million	77,623 Added 397.62%	97,145 $5.23 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $687,118 - $836,276	-20,659 Reduced 51.41%	19,522 $720,000
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $723,757 - $927,342	-29,895 Reduced 42.66%	40,181 $1.25 Million
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $1.05 Million - $1.77 Million	-51,210 Reduced 42.22%	70,076 $1.94 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $969,292 - $1.53 Million	-51,123 Reduced 29.65%	121,286 $3.55 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $1.19 Million - $1.63 Million	62,299 Added 56.58%	172,409 $3.3 Million
Q2 2019 Aug 16, 2019	BUY	$19.57 - $24.1 $1.03 Million - $1.27 Million	52,703 Added 91.81%	110,110 $2.42 Million
Q4 2018 Feb 14, 2019	SELL	$11.24 - $18.5 $6,350 - $10,452	-565 Reduced 0.97%	57,407 $724,000
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $463,196 - $814,506	57,972 New	57,972 $760,000

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.25B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Neogenomics Inc Transaction History